Pediatric Allergic Contact Dermatitis: Sensitization Patterns for a Practical Panel

Merve Şendal1, Nilay Çalışkan2, Deniz Ozceker3

  • 1Department of Pediatrics, Prof. Dr. Cemil Taşçıoğlu City Hospital, Saglik Bilimleri University, Istanbul, Turkey.

Insights

A shortened patch test panel, including 14 key allergens, effectively diagnoses allergic contact dermatitis (ACD) in children. This approach addresses challenges in pediatric allergy testing and improves diagnostic feasibility for young patients.

Area of Science:

  • Dermatology
  • Pediatric Allergy
  • Diagnostic Immunology

Background:

  • Allergic contact dermatitis (ACD) is a growing concern in children.
  • Standard patch testing faces challenges in pediatric populations due to panel limitations and practical constraints.
  • Developing evidence-based pediatric-specific patch test panels is crucial for accurate diagnosis.

Purpose of the Study:

  • To evaluate a practical and shortened patch test panel for diagnosing ACD in children.
  • To identify the most relevant allergens for pediatric patients.
  • To improve the feasibility of patch testing in pediatric settings.

Main Methods:

  • Retrospective analysis of pediatric patients diagnosed with ACD between 2017 and 2021.
  • Patch testing performed using the Thin-Layer Rapid-Use Epicutaneous (T.R.U.E.) Test.
  • Allergen positivity evaluated across different age groups.

Main Results:

  • Nickel was the most common allergen identified in children.
  • Formaldehyde resin, isothiazolinones, and fragrance mix were frequent sensitizers in younger children.
  • A 14-allergen panel successfully identified relevant sensitizations in all pediatric age groups.

Conclusions:

  • Shortened, targeted patch test panels enhance diagnostic feasibility for pediatric ACD.
  • This approach is particularly beneficial in resource-limited settings or when extensive allergen series are unavailable.
  • Optimized patch testing improves the management of allergic contact dermatitis in children.
Abstract

Related Concept Videos

Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Allergic Reactions02:06

Allergic Reactions

Overview
Hypersensitivities01:30

Hypersensitivities

Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...